Table 2.

Characteristics of included studies (N = 6)

Characteristic	Studies
Characteristic	Community Pharmacy Medicines Management Project Evaluation Team¹²	*Dierick-van Daele et al* ¹³**	*Lee et al* ¹⁴**	*Neilson et al* ¹⁵**	*Richardson et al* ¹⁶**	*Turner et al* ¹⁷**
Country of origin	England	Netherlands	South Korea	UK	England	UK
Aims	To assess the cost-effectiveness of a comprehensive community pharmacy medicines management (MEDMAN) service for patients with coronary heart disease	To assess the difference in costs between GPs and nurse practitioners (NPs) in treating common conditions	To assess community health practitioner services in primary care, and to assess the economic impact of these services	To measure the differences in mean costs and effects of a pharmacy-led service for the management of chronic pain in primary care	To assess the cost-effectiveness of nurse-led self-help treatments for patients with chronic fatigue syndrome/myalgic encephalitis in primary care	To assess health service resource use of nurse-led disease management for secondary prevention in patients with chronic heart disease and heart failure in primary care
Type of allied health professional substituting	Pharmacists	Nurse practitioners	CHPs	Pharmacists	Nurses	Nurses
Setting	Nine general practice sites	15 general practices	Random sampling of CHPs working in community health posts	Six general practices	186 general practices	20 general practices
Length of follow-up	12 months	2 weeks	6 months	6 months	70 weeks	12 months
Type of economic evaluation analysis conducted	Cost-minimisation	Cost-minimisation	Cost-minimisation	Cost-utility	Cost-effectiveness	Cost-utility
Primary outcome measure	Appropriate treatment and health status (measured using the SF-36 and EQ-5D)	Direct costs within the healthcare sector and costs outside the healthcare sector (productivity losses)	Activity measures, for example, consultations and cost measures	Differences in mean total costs and effects QALYs	Costs and HRQoL, measured using QALYs	QALYs measured using EQ-5D
Quality assessment score^a	7	9	9	8	9	9

↵a Quality rating based on the number of Drummond questions answered: 0–5 = poor quality, 6–8 = moderate quality, > 9 = good quality.¹¹ CHPs = community health practitioners. EQ-5D = European Quality of Life-5 Dimensions measure. HRQoL = health-related quality of life. QALYS = quality-adjusted life years. SF-36 = Short Form-36 Health Survey.